Financials data is unavailable for this security.
View more
Year on year Merck Tbk PT had little change in net income (from 179.84bn to 178.24bn) despite revenues that fell -14.51% from 1.12tn to 961.43bn.
Gross margin | 34.90% |
---|---|
Net profit margin | 13.36% |
Operating margin | 13.43% |
Return on assets | 13.54% |
---|---|
Return on equity | 16.95% |
Return on investment | 16.05% |
More ▼
Cash flow in IDRView more
In 2023, Merck Tbk PT increased its cash reserves by 18.19%, or 31.01bn. The company earned 203.87bn from its operations for a Cash Flow Margin of 21.21%. In addition the company used 19.90bn on investing activities and also paid 152.96bn in financing cash flows.
Cash flow per share | 371.20 |
---|---|
Price/Cash flow per share | 9.37 |
Book value per share | 1,628.52 |
---|---|
Tangible book value per share | 1,624.30 |
More ▼
Balance sheet in IDRView more
Current ratio | 4.53 |
---|---|
Quick ratio | 1.70 |
Total debt/total equity | 0.0253 |
---|---|
Total debt/total capital | 0.0247 |
More ▼
Growth rates in IDR
SmartText is unavailable
Div yield(5 year avg) | 6.04% |
---|---|
Div growth rate (5 year) | -34.05% |
Payout ratio (TTM) | 114.77% |
EPS growth(5 years) | 36.67 |
---|---|
EPS (TTM) vs TTM 1 year ago | -22.17 |
More ▼